NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review

December 2021 | 43 pages | ID: N14778C0B06EN
GlobalData

Abstracts

NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroScientific Biopharmaceuticals Ltd (NeuroScientific) develops novel pharmaceutical products that target neurological disorders which have high unmet medical needs. The company’s pipeline products include EmtinB therapeutic peptide which is being developed for the treatment of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s Disease, and degenerative conditions of the optic nerve. The company has partnerships with various institute such as Lion’s Eye Institute, and Menzies Institute for Medical Research among others for research and the development of its pipeline product. NeuroScientific is head quartered in Nedlands, Western Australia, Australia.

NeuroScientific Biopharmaceuticals Ltd Key Recent Developments

Aug 24,2021: Neuroscientific Biopharmaceuticals appoints International Scientific Advisors
Jun 22,2021: Paul Rennie appointed Chairman of NeuroScientific
May 31,2021: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
May 18,2021: Neuroscientific Biopharmaceuticals : Resignation of Non-Executive Chairman
Apr 30,2021: NeuroScientific Biopharmaceuticals : March 2021 quarterly activity report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

NeuroScientific Biopharmaceuticals Ltd - Key Facts
NeuroScientific Biopharmaceuticals Ltd - Key Employees
NeuroScientific Biopharmaceuticals Ltd - Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd - Major Products and Services
NeuroScientific Biopharmaceuticals Ltd - History
NeuroScientific Biopharmaceuticals Ltd - Company Statement
NeuroScientific Biopharmaceuticals Ltd - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
NeuroScientific Biopharmaceuticals Ltd - Business Description
NeuroScientific Biopharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
NeuroScientific Biopharmaceuticals Ltd - Strengths
NeuroScientific Biopharmaceuticals Ltd - Weaknesses
NeuroScientific Biopharmaceuticals Ltd - Opportunities
NeuroScientific Biopharmaceuticals Ltd - Threats
NeuroScientific Biopharmaceuticals Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 24, 2021: Neuroscientific Biopharmaceuticals appoints International Scientific Advisors
Jun 22, 2021: Paul Rennie appointed Chairman of NeuroScientific
May 31, 2021: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
May 18, 2021: Neuroscientific Biopharmaceuticals : Resignation of Non-Executive Chairman
Apr 30, 2021: NeuroScientific Biopharmaceuticals : March 2021 quarterly activity report
Mar 31, 2021: Key executive appointments to support upcoming clinical studies
Oct 30, 2020: NeuroScientific Biopharmaceuticals : September 2020 quarterly activity report
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Change of Registered Office and Principal Place of Business Address
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
Jul 30, 2020: NeuroScientific Biopharmaceuticals announces professor Dao-Yi Yu of Lions Eye Institute appointed to Scientific Advisory Board

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

NeuroScientific Biopharmaceuticals Ltd, Key Facts
NeuroScientific Biopharmaceuticals Ltd, Key Employees
NeuroScientific Biopharmaceuticals Ltd, Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd, Major Products and Services
NeuroScientific Biopharmaceuticals Ltd, History
NeuroScientific Biopharmaceuticals Ltd, Key Competitors
NeuroScientific Biopharmaceuticals Ltd, Ratios based on current share price
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios (Cont...1)
NeuroScientific Biopharmaceuticals Ltd, Interim Ratios
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

NeuroScientific Biopharmaceuticals Ltd, Performance Chart (2017 - 2021)
NeuroScientific Biopharmaceuticals Ltd, Ratio Charts
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021